Sandoz, a Novartis company, has launched Glatopa in US markets. Glatopa is the first generic version of Teva’s Copaxone (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy. Read more …
Global Impact of USA withdrawal from TPPA
TPPA – A Boon or Bane ? 
FDA approves new insulin inhaler for diabetics 
Career Development Initiative_CV troubles
Future of drugs-Diabetes_Bexagliflozin
Future of drugs-Diabetes_LIK-066
Future of drugs-Diabetes_Ertugliflozin
Biocon enters pact with Mexican firm to market generic human insulin in US 
